Latest Releases
U.S. Senator Tina Smith’s Statement on the BNSF Train Derailment
WASHINGTON, D.C. [03/30/23] — Today, U.S. Senator Tina Smith (D-Minn.) issued the following statement in response to this morning’s BNSF train derailment in Raymond, Minnesota, and also announced she’s cosponsoring the legislation to improve railway safety standards: “Thanks to the incredible first responders in Raymond and Kandiyohi County, Minnesota, this morning’s train derailment appears to be contained. I’m grateful for their quick response and leadership that kept Minnesotans safe. But today’s derailment is another reminder that Congress needs to act on rail safety now. I’m cosponsoring the bipartisan Railway Safety Act to enact commonsense rail safety measures and help prevent future disasters.” The bipartisan Railway Safety Act was introduced earlier this month by Sen. Sherrod Brown (D-Ohio) and Senator JD Vance (R-Ohio) and is designed to improve safety requirements for trains transporting dangerous or hazardous material and help communities affected by derailments. The bill is also cosponsored by Senators Amy Klobuchar (D-Minn.), Bob Casey (D-Pa.), John Fetterman (D-Pa.), Marco Rubio (R-Fla.), and Josh Hawley (R-Mo.).
U.S. Senators Smith, Braun Reintroduce Bipartisan Legislation to Address Big Pharma Ploy That Keeps Drug Prices High for Consumers
WASHINGTON – Today, U.S. Senators Tina Smith (D-MN) and Mike Braun (R-IN), reintroduced bipartisan legislation to address a big pharma ploy that prevents access to affordable prescription drugs for millions of people across the country. The Expanding Access to Low-Cost Generics Act—which was the first piece of Senate legislation introduced by Sen. Smith in 2018—addresses an anti-competitive prescription drug practice called “parking.” “Parking” occurs when a brand name manufacturer agrees not to sue the first company that submits an application to create a generic version of that drug—a so-called “first filer”—as long as the generic company agrees to delay bringing that generic drug to market. No other company can bring a generic version of a brand name drug to market until 180 days after the first filer has done so. These anti-competitive agreements among drug companies allow fewer lower-cost generic products to come to market and keep prices higher for consumers. Right now at least 75 percent of “first filer” generic products have delayed their market entry due to “parking” arrangements with brand-name companies. The Senators’ bipartisan bill takes major steps toward eliminating this practice. “When I travel around Minnesota, the high price of prescription drugs is always one of the first things families and seniors talk to me about,” said Sen. Smith, a member of the Senate Health Committee. “This bill takes important steps toward ending anti-competitive practices that big pharmaceutical companies exploit to keep drug prices high and unaffordable for people in Minnesota and across the country.” “Everywhere
U.S. Senator Tina Smith in Senate Speech: “Why I’m Sharing My Experience with Depression”
WASHINGTON, D.C. [05/15/19]—Today, U.S. Senator Tina Smith (D-Minn.) took to the Senate floor to share her own mental health story as part of her push to make access to mental health care for Minnesotans and Americans a top priority. In her speech, Sen. Smith—a member of the Senate Health Committee—shared her own experiences with depression earlier in life, and highlighted the need to provide mental health support to people at every age across the nation in both rural and urban areas, no matter what zip code they live in. “That’s my story. Really, it’s the story of millions of
U.S. Senator Tina Smith Calls for Action to Protect Homebuyers from Predatory Lending
WASHINGTON, D.C. [05/13/19]—U.S. Senator Tina Smith (D-Minn.) is calling on the Consumer Financial Protection Bureau (CFPB)—to improve protections for Minnesotans and Americans purchasing manufactured homes, after hearing from multiple consumer advocates that unwitting home buyers are often steered toward higher-cost loans. Sen. Smith—a member of the Senate Banking, Housing, and Urban Affairs—and eight of her Senate colleagues highlighted the lack of transparency manufactured homebuyers face when it comes to lending practices in a letter to CFPB Director Kathy Kraninger. The letter was led by Sen. Catherine Cortez Masto (D-Nev.). “Typically, the majority of consumers who have not
Klobuchar Introduces Legislation to Provide Relief to Those Caring for Aging Relatives
WASHINGTON D.C. [05/10/2019] – U.S. Senator Amy Klobuchar (D-MN) reintroduced the Americans Giving Care to Elders (AGE) Act to provide financial relief to caregivers by creating a tax credit for the costs of caring for an aging relative. The AGE Act would allow families to qualify for a tax credit to help offset expenses—ranging from purchasing assistive technologies and devices, respite care, to making necessary home modifications—of up to $6,000 per year. Klobuchar first introduced the AGE Act in 2015. The bill is co-sponsored by Senators Mazie K. Hirono (D-HI), Tina Smith (D-MN), and Dianne Feinstein (D-CA). “We know that caregiving can be extremely expensive—especially when family
U.S. Senator Tina Smith Pushes for Prescription Drug Pricing Transparency
WASHINGTON, D.C. [05/09/19]—Today, U.S. Senator Tina Smith (D-Minn.) helped introduce bipartisan legislation to combat skyrocketing prescription drug prices. The Fair Accountability and Innovative Research (FAIR) Drug Pricing Act would require drug manufacturers to disclose and provide more information about planned drug price increases, including research and development costs. Increased transparency will help provide much-needed context for taxpayers, consumers, and policymakers about the costs and value of medications, and may also incentivize companies to reassess the long-standing practice of relentless drug price increases. The bill was led by Sens. Tammy Baldwin (D-Wisc.) and Mike Braun (R-Ind.), and Sen. Lisa Murkowski (R-Alaska) is a cosponsor. I’ve traveled around Minnesota to talk
English